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How do I perform Whole Blood Exchange? 
 
1. Introduction 
There are a number of clinical scenarios where simultaneous exchange of the 
patient’s plasma and red blood cells (RBC) are indicated. Some of the clinical indications 
for therapeutic whole blood exchange (WBEx) include hemolytic disease of the newborn 
(HDFN), severe autoimmune hemolytic anemia (AIHA), babesiosis, sickle cell disease, 
and hyperleukocytosis 1, 2, 3, 4. WBEx has been performed with manual, semi-automated, 
and fully automated methods using replacements fluids (i.e. RBC with plasma, RBC with 
5% albumin, and whole blood (WB)) reconstituted to a pre-specified target hematocrit 
(Hct); however, methodologies vary widely and each carry advantages and 
disadvantages. Here, we describe our combined experiences in performing WBEx, 
including clinical indications, technical methods, and issues related to their application 
in the treatment of patients.    
 
2. Manual WBEx 
2A. Immune Hemolytic Anemia  
Manual WBEx has been used in pediatric and adult patients with severe AIHA 
with brisk hemolysis that is unresponsive to standard treatment and simple transfusion 
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5, 6, 7, 8. Manual WBEx for severe AIHA has several potential advantages over therapeutic 
plasma exchange (TPE) alone. First and foremost, WBEx can remove both free and RBC-
bound antibodies. Furthermore, the infusion and subsequent removal of donor RBC 
over the course of several hours permits an “in vivo allo-adsorption” of autoantibodies, 
with reduction in autoantibody titers. In many cases, a single WBEx effected a dramatic 
decrease in hemolysis 5, 6, 7. WBEx may slow hemolysis through removal of antibodies, 
sensitized RBCs, and hemoglobin byproducts (free iron, methemoglobin) – the latter are 
hypothesized to synergize and amplify hemolysis in malaria and other chronic non-
immune mediated hemolytic conditions such as sickle cell anemia 9, 10.  
  
 At the University of Michigan, manual WBEx method for severe AIHA is 
performed similar to that for HDFN. Reconstituted WB is prepared with type-specific 
RBC and plasma to a target Hct of 50% for a 1x-2x blood volume exchange. We opted for 
a target Hct of 50% for the replacement fluid given the severity of the hemolytic anemia. 
Selected RBC units were <15 days of age, matched for Rh, Kell, Jk and other antigens as 
appropriate based on history and serology, and crossmatched against plasma or 
adsorbed plasma, if available. Because preparation of reconstituted WB is considered an 
open system with a 24 hour outdate, we prepared only one reconstituted WB unit at a 
time (i.e. after dispensing one unit, the next unit was prepared). WBEx was performed 
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by physically removing WB with a syringe, followed by infusion of reconstituted WB. In 
adult patients, this involved removal of 200 mL (50 mL per draw with 60 mL syringes) 
over 10 minutes through a triple lumen central venous catheter, followed by infusion of 
WB over 1 to 1.5 hours. Overall, it required 20 hours to complete a manual WBEx 
exchange with 12 units WB as replacement. For pediatric patients, a similar process was 
followed using a central or femoral venous catheter (5 mL/kg per draw).  We advise 
against the use of peripherally inserted central catheters (PICC) lines for manual WBEx 
based on our experience of losing PICC line access early in the process of a manual 
WBEx in both adult and pediatric patients.   
 We have performed manual WBEx in 3 patients with life-threatening AIHA with 
marked, sustained improvement in 2 patients. Our first patient was a 19-year old male 
with warm AIHA with hemolysis-induced hyperlipidemia, methemoglobinemia, 
hypertension, volume overload, hypoxia, in vivo RBC agglutination and worsening 
hemolysis despite high dose steroids, IVIG and splenectomy5. After a single WBEx, his 
hemoglobin was 7.7 g/dL with resolution of autoagglutination, decrease in autoantibody 
(titers fell from 1000 to 256), decreased methemoglobin (14% to 1%), and marked 
improvement in hemolysis and organ function (Figure 1). Our second case was a 4 year-
old with severe WAIHA due to weak affinity IgG. A single WBEx increased his Hct from 
5.4% to 33%, decreased methemoglobin (15.4% to 2%) and improved oxygenation (from 
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83% O2 on 100% FiO2 to 99% O2 on room air). Similar results were reported in a 2-
month and 10-year old who were also treated for AIHA using manual WBEx 6, 7.  A single 
WBEx was also reported to rapidly improve hemolysis due to passenger lymphocyte 
syndrome in an ABO-incompatible, allogeneic peripheral blood stem cell transplant 11.   
In contrast, WBEx may have limited efficacy in AIHA with a warm IgM 
component. We performed three manual WBEx in a post-transplant patient with a 
severe refractory mixed AIHA that included a warm IgM component. Although there was 
a transient improvement in Hct, severe hemolysis recurred within 48-72 hours after the 
procedure. Repeated WBEx also failed to suppress hemolysis in two other pediatric 
patients with warm IgM AIHA 12, 13. WBEx was also ineffective in cold AIHA due to anti-Pr 
14. 
 
2B. Hyperleukocytosis and Other Indications  
Manual WBEx has been used to treat pediatric patients with hyperleukocytosis 
due to acute leukemia, pertussis, methemoglobinemia, poisoning, neonatal sepsis, 
thrombotic thrombocytopenia purpura (TTP), and Guillian-Barre syndrome 4, 15, 16, 17, 18, 
19, 20, 21, 22, 23, 24, 25. Manual WBEx may be particularly advantageous in the setting of acute 
leukemia and sepsis because of the ability to also address anemia and clotting 
abnormalities. In neonatal sepsis, manual WBEx has been show to decrease overall 
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mortality and improved renal output 26. Manual WBEx for TTP and other disorders were 
performed due to the patient’s young age or lack of apheresis services 19, 20, 21, 22. 
 In small children (<10-15 kg body weight), manual WBEx may be a more suitable, 
safer and faster option than apheresis. Unlike apheresis, several venous access options 
are available for manual WBEx. In small children (≤10 kg), leukoreduction can be 
performed faster by manual WBEx than leukapheresis with equivalent results 4, 16, 17. A 
10-year review at the University of Michigan showed that leukapheresis in this 
population took 8-24 hours due to access and procedure issues. In children < 10 kg, a 2x 
blood volume leukapheresis averaged 3 hours due to the need for blood prime, slow 
inlet rate (1-2 mL/kg/min) and delays in establishing an interface. Since 2010, manual 
WBEx is performed in children < 10 kg for hyperleukocytosis. 
In hyperleukocytosis and other conditions, manual WBEx has been performed 
with actual WB, or reconstituted WB with a Hct of 24% to 30%.  The exception is WBEx 
for pertussis, in which a Hct of 40% is recommended 27. Alternatively, type-specific fresh 
WB from a donor can be used 4, 19, 20. 
 
3. Semi-Automated WBEx Transfusion 
In the 1940’s, WBEx transfusion was first used as a treatment for 
erythroblastosis fetalis.  A continuous process using both arterial and venous umbilical 
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vessels for flow was reported by Ata and Holman 28.  In this method, gravity was used to 
remove blood and replace at equal speeds.  The use of dual infusion pumps for an 
isovolumetric exchange was reported by Cropp 29.  Subsequent modifications of this 
process introduced dual lumen catheters and different styles of infusion pumps 30, 31, 32. 
In these semi-automated WBEx procedures, 1x WB volume exchange is usually 
performed in an isovolumetric fashion (Figure 2). The flow rate of the pumps removing 
and transfusing blood are equivalent and the replacement fluid is reconstituted WB 
from the blood bank.  Because both circuits can be primed, there is minimal 
extracorporeal volume. The automation allows for greater flow speeds and more rapid 
completion of the procedure.  
At Roswell Park, we used a semi-automated WBEx method to treat a 53 year-old 
adult with a malignancy-related AIHA refractory to steroids, IVIG, and the first dose of 
rituximab 33. His initial hemoglobin of less than 4 g/dL with accompanying chest pain 
was considered too low to allow for use of an automated apheresis device. Eight semi-
automated WBEx procedures were performed over a 9-day period using approximately 
1000 ml of reconstituted WB per procedure.  A central line was used for vascular access 
with the draw and return lines connected to separate infusion pumps. The replacement 
fluid was RBC reconstituted using 5% human serum albumin to a target Hct within 3% 
that of the WB being removed to reduce the risk of developing pulmonary edema during 
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the procedure 34.  Limiting the Hct in the replacement fluid was based on a warning to 
individuals performing automated RBC exchange not to increase the Hct by more than 
3% because of the significant risk of inducing pulmonary edema. Changes in the 
software now prevent this from occurring in the automated system. This patient 
continued to have active hemolysis but required less intensive RBC transfusion support.  
 
4. Fully Automated, Continuous-Flow WBEx Transfusion 
Three fully automated, continuous-flow methods for WBEx transfusion have 
been previously reported (Table 1). Berkessy reported a method using the Kiil dialyzer 
(both arterial tubing and venous tubing are pumped by the same roller-pump element 
to maintain constant blood volume) to treat hepatic coma and poisoning with non-
dialyzable substances 35. Dorman successfully treated an adult patient with fulminant 
babesiosis with WBEx transfusion using the COBE Spectra RBC Exchange protocol and 
the following exchange program parameters: pre-exchange Hct 32%, replacement fluid 
Hct 33% (RBC reconstituted with plasma), target Hct 30%, and FCR 30% (fluid balance % 
was not reported) 36. Li et al reported clinical outcomes from a cohort of 30 adult 
patients with severe AIHA treated with WBEx transfusion using the COBE Spectra TPE 
protocol 37. This procedure, however, required running the TPE procedure in manual 
mode so that the RBC line valve is closed to divert separated RBC and plasma together 
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into the discard bag via the plasma line. Replacement fluids (donor RBCs and plasma) 
were not reconstituted beforehand, but are mixed in real-time within the replacement 
fluid tubing (i.e. replacement fluid spike #1 to donor RBC, and spike #2 to donor 
plasma).  
In comparison, Bloodworks’ validated WBEx protocol using the Spectra Optia is 
fully automated, and takes advantage of FDA 510(k) cleared Red Blood Cell Exchange 
(RBCX) protocol 38. Based upon the observation at Bloodworks that a median plasma 
volume (PV) of 0.34 (interquartile range of 0.33 to 0.36 PV) is simultaneously exchanged 
in sickle cell patients on a chronic RBCX program using replacement fluid with median 
Hct of 56%, and applying the principle of RBC conservation (i.e. (Total Blood Volume 
(TBV) x target Hct) + (Remove Volume x Remove Hct) = (TBV x pre-Hct) + (Replacement 
Volume x Replacement Fluid Hct) ) in a closed patient-apheresis system, approximately 
a 1.0 PV can be exchanged while simultaneously achieving a fractional cell remaining 
(FCR) target of 35% by simply diluting the replacement fluid to the patient’s pre-
exchange HCT 39.  
 This fully automated WBEx procedure was used to treat a 50 year-old adult with 
a new severe symptomatic WAIHA and an initial hemoglobin of 4.4 g/dL refractory to 
steroid, IVIG, and rituximab despite a total of 40 units of Rh and Kell antigen-matched 
RBC transfusion support over 2 weeks 40. A total of approximately 6.7 liters of 
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replacement fluid (RBC reconstituted with 5% albumin to an expected Hct of 21%) was 
used to achieve target Hct of 20% and FCR of 35% (Figure 3). The patient tolerated the 
WBEx procedure well, the initial run values were attained, and the antihuman globulin 
autoantibody titer fell from 8 to 2. The patient eventually recovered after a prolonged 
hospital stay that included additional immunosuppressive therapies, including 
cyclophosphamide, and splenic-artery embolization. 
 
5. Conclusion 
As described, experiences from multiple institutions demonstrated that it is feasible to 
perform WBEx for several clinical indications.  While the reported case number is small, 
some clinical benefit of WBEx has been shown for certain clinical indications.  All of the 
reported methods and techniques have their own unique set up and challenges.  More 
studies and technology advancement are needed in the future to firmly establish clinical 
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Instrument Advantages Disadvantages Technical Aspects 





Kiil dialyzer Fully automated,  
continuous flow 
Historical technology Both arterial tubing and 
venous tubing are pumped 
by the same roller-pump 
element to maintain 









Recently phased out 
technology; 
reconstituting RBC to 
the intended Hct is 
labor intensive 
Reconstitute RBC with 
plasma to a target Hct as 
close to the patient’s pre-
exchange Hct, and program 
FCR at 30%.  







Recently phased out 
technology; 
reconstituting RBC in 
real-time may result in 
variable replacement 
fluid Hct 
RBC line valve is closed so 
that WB is diverted (via the 
plasma line) into the discard 
bag. Replacement fluid spike 
#1 to donor RBC, and spike 









Reconstituting RBC to 
the intended Hct is 
labor intensive 
Reconstitute RBC with 
compatible fluid to Hct as 
close to the patient’s pre-
exchange Hct, and program 
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Fig 1. Clinical course of an adult male with life-threatening AIHA that was treated with 
manual WBEx. A) Improved hemoglobin (), resolution of red cell autoagglutination 
() and marked decrease in hemolysis and transfusion requirement following WBEx. B) 
Decrease in FiO2 requirement ( - - -) with extubation following manual WBEx and 
removal of methemoglobin. 
 
Fig 2. Semi-automated WBEx procedures are isovolumetric, i.e. The flow rate of the 
pumps removing and transfusing blood are equivalent 
 
Fig 3. Fully automated, continuous-flow method for WBEx using the Spectra Optia 
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